人乳寡糖(HMO) 市场规模、份额和成长分析（按类型、产品、应用、分销管道和地区）- 2025-2032 年产业预测

2023 年人乳寡糖(HMO) 市场规模价值为 2.082 亿美元，预计将从 2024 年的 2.2964 亿美元增长到 2032 年的 5.0311 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.3%。

人乳寡糖(HMO) 市场作为婴儿营养和健康的关键组成部分，正日益受到关注，并认识到其众多的健康益处。母乳中天然存在的 HMO 可促进免疫系统成熟、胃肠道健康和认知发展。随着研究的不断深入，HMO 的潜在用途正在扩展到药品、机能性食品和益生元补充剂。市场成长的主要驱动力包括人们对 HMO 健康益处的认识不断提高，以及让婴儿奶粉更类似于母乳的动力。然而，挑战依然存在，包括 HMO 生产的复杂性和高成本，以及监管和智慧财产权问题。儘管如此，正在进行的研究表明，HMO 不仅可以改善婴儿营养，还可以解决整个生命週期中更广泛的健康问题，这表明 HMO 在医疗保健和机能性食品领域有着变革性的未来。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

人乳寡糖(HMO) 市场规模（按类型和复合年增长率）（2025-2032 年）

• 市场概况
• 2'FL
• 3'FL
• 3'SL
• 6'SL

人乳寡糖(HMO) 市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 岩藻糖基乳糖
• 乳糖-N-四糖和乳糖-N-新四糖
• 唾液乳糖

人乳寡糖(HMO) 市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 婴儿奶粉
• 机能性食品和饮料
• 营养补充品
• 人类和动物健康成分
• 其他的

人乳寡糖(HMO) 市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 大卖场和超级市场
• 药局或药房
• 量贩店
• 百货公司
• 单一品牌店
• 专卖店
• 网路销售管道

人乳寡糖(HMO) 市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• DSM（Netherlands）
• BASF SE（Germany）
• DuPont（US）
• Nestle（Switzerland）
• Inbiose NV（Belgium）
• Gnubiotics Sciences SA（Switzerland）
• Abbott Laboratories（US）
• Royal FrieslandCampina NV（Netherlands）
• Elicityl SA（France）
• Dextra Laboratories（UK）
• Glycom A/S（Denmark）
• Glycosyn（US）
• Medolac Laboratories（US）
• Neolacta Lifesciences Pvt. Ltd.（India）
• Jennewein Biotechnologie GmbH（Germany）
• Lonza Specialty Ingredients（Switzerland）
• Kirin Holdings Company（Kyowa Hakko Bio）（Japan）
• ZuChem Inc.（US）

结论和建议

Human Milk Oligosaccharides (HMO) Market size was valued at USD 208.2 million in 2023 and is poised to grow from USD 229.64 million in 2024 to USD 503.11 million by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The human milk oligosaccharides (HMO) market is gaining traction as a crucial component of infant nutrition and wellness, recognized for its myriad health benefits. Naturally occurring in breast milk, HMOs promote immune system maturation, gastrointestinal health, and cognitive development. As research advances, their potential applications are expanding into pharmaceuticals, functional foods, and prebiotic supplements. Key drivers of market growth include increasing awareness of HMOs' health benefits and the push to make infant formulas more akin to breast milk. However, challenges such as the complexity and high costs of HMO production, along with regulatory and intellectual property issues, remain significant. Nonetheless, ongoing research promises not only to enhance infant nutrition but also to address broader health concerns throughout the life cycle, indicating a transformative future for HMOs in healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (Hmo) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Human Milk Oligosaccharides (Hmo) Market Segments Analysis

Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Human Milk Oligosaccharides (Hmo) Market

The rising recognition of the health benefits associated with human milk oligosaccharides (HMOs) serves as a significant catalyst for the market's expansion. As consumers become more informed about how HMOs contribute to enhanced immune function, cognitive growth, and gastrointestinal health, especially in infants, the demand for products fortified with these beneficial compounds has surged. This increased interest not only reflects parents' desire to provide optimal nutrition for their children but also highlights potential advantages for adults, further driving market growth. Consequently, the HMO market is experiencing a robust uptick, fueled by escalating awareness of their nutritional advantages.

Restraints in the Human Milk Oligosaccharides (Hmo) Market

The Human Milk Oligosaccharides (HMO) market faces significant restraints due to the intricate and challenging nature of HMO synthesis. The complexity of the processes involved complicates the scalability of HMO production, making it more difficult to achieve cost-effective manufacturing. The diverse array of HMO structures found in breast milk necessitates sophisticated and expensive techniques for replication, further hindering the industry's ability to produce these valuable components efficiently. As a result, these factors may limit the widespread availability and affordability of HMOs, ultimately impacting market growth and accessibility for potential consumers and manufacturers alike.

Market Trends of the Human Milk Oligosaccharides (Hmo) Market

The Human Milk Oligosaccharides (HMO) market is witnessing a significant trend towards expanding applications beyond traditional infant nutrition. While HMOs have primarily been associated with breastfeeding, their potential is now being explored in various sectors, including functional foods, dietary supplements, and pharmaceutical products. This shift is driven by growing scientific research showcasing the health benefits of HMOs, such as immune support and gut health improvement, for individuals across different age groups. Consequently, manufacturers are actively investing in developing innovative HMO-based solutions, positioning the market for substantial growth as consumer awareness of these benefits continues to rise.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2025-2032)

• Market Overview
• 2'FL
• 3'FL
• 3'SL
• 6'SL

Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Fucosyllactose
• Lnt & LNnt
• Sialyllactose

Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infant formula
• Functional food & beverages
• Food supplements
• Health ingredients for human and animal
• Other

Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2025-2032)

• Market Overview
• Hypermarkets and supermarkets
• Drug store or pharmacy
• Mass merchandiser
• Departmental stores
• Mono-brand stores
• Specialty stores
• Online sales channel

Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2025-2032)

• North America (Type, Product, Application, Distribution channel)
  • US
  • Canada
• Europe (Type, Product, Application, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Application, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Application, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Application, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inbiose NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gnubiotics Sciences S.A (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal FrieslandCampina N.V (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elicityl S.A (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextra Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycom A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycosyn (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medolac Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neolacta Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jennewein Biotechnologie GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Specialty Ingredients (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZuChem Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations